Phospholipase A2 is involved in chemotaxis of human leukocytes.
Tibes
U
U
Boehringer Mannheim GmbH, Dept. of Preclinical Research, Mannheim.
Hinder
M
M
Scheuer
W
W
Friebe
W G
WG
Schramm
S
S
Kaiser
B
B
D000328:Adult; D001094:Arachidonate 5-Lipoxygenase / Q000378:metabolism; D016718:Arachidonic Acid / Q000378:metabolism; D002634:Chemotaxis, Leukocyte / Q000187:drug effects / Q000502:physiology*; D015232:Dinoprostone / Q000096:biosynthesis; D004791:Enzyme Inhibitors / Q000494:pharmacology; D006801:Humans; D066298:In Vitro Techniques; D007527:Isoenzymes / Q000378:metabolism; D007962:Leukocytes / Q000187:drug effects / Q000201:enzymology* / Q000502:physiology*; D007975:Leukotriene B4 / Q000096:biosynthesis; D008297:Male; D008875:Middle Aged; D009240:N-Formylmethionine Leucyl-Phenylalanine / Q000494:pharmacology; D054799:Phospholipase C beta; D010741:Phospholipases A / Q000037:antagonists & inhibitors / Q000502:physiology*; D054467:Phospholipases A2; D011451:Prostaglandin-Endoperoxide Synthases / Q000378:metabolism; D011796:Quinacrine / Q000494:pharmacology; D012969:Sodium Fluoride / Q000494:pharmacology; D013141:Spiro Compounds / Q000494:pharmacology; D013729:Terpenes / Q000494:pharmacology; D010738:Type C Phospholipases / Q000378:metabolism
D004791:Enzyme Inhibitors; D007527:Isoenzymes; D013141:Spiro Compounds; D013729:Terpenes; C111593:BM 162115; D007975:Leukotriene B4; D016718:Arachidonic Acid; D009240:N-Formylmethionine Leucyl-Phenylalanine; D012969:Sodium Fluoride; C045673:manoalide; D001094:Arachidonate 5-Lipoxygenase; D011451:Prostaglandin-Endoperoxide Synthases; D010741:Phospholipases A; D054467:Phospholipases A2; D010738:Type C Phospholipases; D054799:Phospholipase C beta; D011796:Quinacrine; D015232:Dinoprostone